If you need more lookups,
subscriptions start at $34 USD/month.
Thomas Hoffmann Location
Vienna, AT
Thomas Hoffmann Work
Chief Technology Officer @ (June 2024 - Present)
VP of Science @ (October 2023 - May 2024)
Scientist @ (November 2021 - September 2023)
Scientist @ Accanis (July 2017 - September 2023)
Postdoc @ (May 2011 - July 2017)
Diploma Student @ Ludwig Boltzmann Institute for Cancer research (September 2010 - November 2011)
Student @ (September 2005 - August 2010)
Thomas Hoffmann Education
University of Vienna
Doctor of Philosophy (Ph.D.) (Molecular Biology)
2006-2015
HBLVA Rosensteingasse
Engineer’s Degree (Chemistry; Biochemistry and Biotechnology)
2000-2005
Thomas Hoffmann Skills
mRNA
Optimization
RNAi
Crispr
Cas9
Next generation Sequencing
Cell Culture
Cell Biology
Molecular Cloning
Molecular Biology
Molecular & Cellular Biology
Western Blotting
Southern Blot
shRNA
advanced RNAi
FACS analysis
PCR
Life Sciences
Polymerase Chain Reaction (PCR)
Gene Therapy
ELISA
Mouse Models
qPCR
Thomas Hoffmann Summary
Thomas Hoffmann, based in Vienna, AT, is currently a Chief Technology Officer at ADvantage Therapeutics Inc.. Thomas Hoffmann brings experience from previous roles at ADvantage Therapeutics Inc., Accanis and Research Institute of Molecular Pathology. Thomas Hoffmann holds a 2006 - 2015 Doctor of Philosophy (Ph.D.) in Molecular Biology @ University of Vienna. With a robust skill set that includes mRNA, Optimization, RNAi, Crispr, Cas9 and more. Thomas Hoffmann has 2 emails on RocketReach.
Looking for a different Thomas Hoffmann?
Find contact details for 700 million professionals.